Ophthalmologists should be able to prescribe bevacizumab, says royal college
Sign Up to like & getrecommendations! Published in 2017 at "British Medical Journal"
DOI: 10.1136/bmj.j5139
Abstract: Ophthalmologists should be able to prescribe the most appropriate treatment for wet age-related macular degeneration, including off-label bevacizumab (Avastin), provided that patients give their informed consent, the Royal College of Ophthalmologists has said. The college… read more here.
Keywords: ophthalmologists able; college; royal college; college ophthalmologists ... See more keywords